Evidence map›Paper›PMID 40574079›Full record

ArticlePharmaceutics2025

Stability-Guided Formulation of a Light-Sensitive D-LSD Capsule for Clinical Investigation.

Bernard Do, Luc Mallet, Maxime Annereau, Danielle Libong, Audrey Solgadi, Florence Vorspan, Muriel Paul, Philippe-Henri Secretan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bernard DoClinical Pharmacy Department, Gustave Roussy Cancer Campus, 94805 Villejuif, France.
Luc MalletUniversité Paris-Est Créteil, DMU IMPACT, Département Médical-Universitaire de Psychiatrie et d'Addictologie, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris, 94000 Créteil, France.
Maxime AnnereauClinical Pharmacy Department, Gustave Roussy Cancer Campus, 94805 Villejuif, France.ORCID 0000-0001-9594-2516
Danielle LibongLip(Sys)2-Chimie Analytique Pharmaceutique, Université Paris-Saclay, 91400 Orsay, France.
Audrey SolgadiUMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, 91400 Orsay, France.ORCID 0000-0002-6135-0050
Florence VorspanUniversité Paris Cité, INSERM UMRS 1144 Optimisation Thérapeutique en Neuropharmacologie, 75006 Paris, France.ORCID 0000-0001-5168-3727
Muriel PaulDepartment of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Créteil, France.
Philippe-Henri SecretanMatériaux et Santé, Université Paris-Saclay, 91400 Orsay, France.ORCID 0000-0002-5838-3695

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

degradation productsDFTD-LSDformulation developmentLC-IM-MSorthogonal analysisphotostability

Identifiers

PMID40574079
PMCPMC12196330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.